Rick Wise
Stock Analyst at Stifel Nicolaus
(3.15)
# 2,550
Out of 5,090 analysts
812
Total ratings
50.4%
Success rate
1.6%
Average return
Main Sectors:
Stocks Rated by Rick Wise
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SYK Stryker | Maintained: Buy | $330 → $325 | $291.86 | +11.35% | 36 | Nov 2, 2026 | |
| BAX Baxter International | Reiterated: Hold | $28 → $25 | $23.00 | +8.70% | 38 | Oct 30, 2026 | |
| GEHC GE HealthCare Technologies | Reiterated: Buy | $80 → $90 | $76.57 | +17.54% | 19 | Oct 29, 2026 | |
| KIDS OrthoPediatrics | Reiterated: Buy | $24 → $27 | $30.87 | -12.54% | 34 | Oct 28, 2026 | |
| LUNG Pulmonx | Rated: Buy | $2.5 → $4 | $3.01 | +33.11% | 23 | Oct 28, 2026 | |
| BSX Boston Scientific | Reiterated: Buy | $60 → $55 | $41.98 | +31.01% | 68 | Oct 26, 2026 | |
| ABT Abbott Laboratories | Reiterated: Buy | $120 | $106.20 | +12.99% | 45 | Oct 22, 2026 | |
| ISRG Intuitive Surgical | Reiterated: Buy | $550 | $432.01 | +27.31% | 50 | Oct 21, 2026 | |
| JNJ Johnson & Johnson | Reiterated: Hold | $260 | $273.20 | -4.83% | 32 | Oct 12, 2026 | |
| SOLV Solventum | Reiterated: Buy | $100 | $81.33 | +22.96% | 13 | Sep 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $65 | $61.25 | +6.12% | 36 | Sep 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $29.69 | +1.04% | 9 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $80 → $95 | $96.54 | -1.60% | 51 | Sep 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $45 | $59.05 | -23.79% | 7 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $195 | $197.88 | -1.46% | 33 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $4.5 | $4.43 | +1.58% | 25 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $22.58 | +99.29% | 21 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $4.03 | +48.88% | 31 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13.96 | $9.18 | +52.12% | 11 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $50 → $45 | $32.12 | +40.10% | 4 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $105 → $110 | $94.52 | +16.38% | 48 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 → $85 | $78.97 | +7.64% | 37 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 | $80.94 | +48.26% | 26 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 | $92.01 | +19.55% | 51 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $55 | $44.29 | n/a | 32 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $0.000001 | n/a | 8 | Jun 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $25 → $30 | $1.80 | n/a | 13 | Feb 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25 → $34 | $19.11 | n/a | 9 | Aug 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $551.21 | n/a | 2 | Nov 8, 2012 |
Stryker
Nov 2, 2026
Maintained: Buy
Price Target: $330 → $325
Current: $291.86
Upside: +11.35%
Baxter International
Oct 30, 2026
Reiterated: Hold
Price Target: $28 → $25
Current: $23.00
Upside: +8.70%
GE HealthCare Technologies
Oct 29, 2026
Reiterated: Buy
Price Target: $80 → $90
Current: $76.57
Upside: +17.54%
OrthoPediatrics
Oct 28, 2026
Reiterated: Buy
Price Target: $24 → $27
Current: $30.87
Upside: -12.54%
Pulmonx
Oct 28, 2026
Rated: Buy
Price Target: $2.5 → $4
Current: $3.01
Upside: +33.11%
Boston Scientific
Oct 26, 2026
Reiterated: Buy
Price Target: $60 → $55
Current: $41.98
Upside: +31.01%
Abbott Laboratories
Oct 22, 2026
Reiterated: Buy
Price Target: $120
Current: $106.20
Upside: +12.99%
Intuitive Surgical
Oct 21, 2026
Reiterated: Buy
Price Target: $550
Current: $432.01
Upside: +27.31%
Johnson & Johnson
Oct 12, 2026
Reiterated: Hold
Price Target: $260
Current: $273.20
Upside: -4.83%
Solventum
Sep 18, 2026
Reiterated: Buy
Price Target: $100
Current: $81.33
Upside: +22.96%
Sep 17, 2026
Reiterated: Buy
Price Target: $50 → $65
Current: $61.25
Upside: +6.12%
Sep 15, 2026
Reiterated: Buy
Price Target: $30
Current: $29.69
Upside: +1.04%
Sep 2, 2026
Reiterated: Hold
Price Target: $80 → $95
Current: $96.54
Upside: -1.60%
Aug 14, 2026
Reiterated: Buy
Price Target: $40 → $45
Current: $59.05
Upside: -23.79%
Aug 11, 2026
Reiterated: Buy
Price Target: $195
Current: $197.88
Upside: -1.46%
Aug 11, 2026
Reiterated: Hold
Price Target: $3 → $4.5
Current: $4.43
Upside: +1.58%
Aug 7, 2026
Reiterated: Buy
Price Target: $45
Current: $22.58
Upside: +99.29%
Aug 7, 2026
Reiterated: Buy
Price Target: $6
Current: $4.03
Upside: +48.88%
Aug 7, 2026
Reiterated: Buy
Price Target: $13.96
Current: $9.18
Upside: +52.12%
Aug 6, 2026
Rated: Buy
Price Target: $50 → $45
Current: $32.12
Upside: +40.10%
Aug 6, 2026
Rated: Buy
Price Target: $105 → $110
Current: $94.52
Upside: +16.38%
Aug 5, 2026
Reiterated: Buy
Price Target: $80 → $85
Current: $78.97
Upside: +7.64%
Aug 5, 2026
Reiterated: Buy
Price Target: $120
Current: $80.94
Upside: +48.26%
Jul 24, 2026
Reiterated: Buy
Price Target: $110
Current: $92.01
Upside: +19.55%
May 1, 2025
Reiterated: Hold
Price Target: $55
Current: $44.29
Upside: n/a
Jun 3, 2023
Reiterated: Hold
Price Target: $1
Current: $0.000001
Upside: n/a
Feb 25, 2019
Upgraded: Buy
Price Target: $25 → $30
Current: $1.80
Upside: n/a
Aug 22, 2018
Reiterated: Hold
Price Target: $25 → $34
Current: $19.11
Upside: n/a
Nov 8, 2012
Rated: Hold
Price Target: n/a
Current: $551.21
Upside: n/a